Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
about
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineOvarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionUpdate in genetic susceptibility in melanomaAmerican Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providersPatient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.To worry or not to worry: breast cancer genetic counseling communication with low-income Latina immigrantsGenetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Perceived versus objective breast cancer risk in diverse women.Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective studySeeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutationImplementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.Development of a communication protocol for telephone disclosure of genetic test results for cancer predispositionDifferences in BRCA counseling and testing practices based on ordering provider type.Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of FloridaFactors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersGenetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject.Prevalence and detection of psychosocial problems in cancer genetic counseling.Genetics and Personal Insurance: the Perspectives of Canadian Cancer Genetic Counselors.Diagnostic Approach to Hereditary Colorectal Cancer Syndromes.Genetic counseling in melanoma.Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key.Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items.Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared InformationA statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.Breast cancer in the young: role of the geneticistHereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era.Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk.Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityTwo novel sequence variants in MSH2 gene in a patient who underwent cancer genetic counseling for a very early-onset epithelial ovarian cancerHow, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.Next-generation sequencing in the clinic: are we ready?BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
P2860
Q26740273-7EC2146D-EF2D-44B8-9736-70AC27871ACEQ26744525-0EBFBDD7-6232-4F1F-9120-21C2FD7A5B50Q26778756-DD1781CE-66B2-40C4-BFAA-0EDDD9286F36Q30416965-13982B4A-9134-432D-8674-F0D8B9497C5DQ30543371-2E3DFE5E-DFC0-4C3A-A275-2A75D97D3B26Q30613390-A22C842F-4931-401D-9F1B-D5C7CD7ACF49Q33564013-61E3A740-8A78-4A75-B583-5BE1D7AAE84FQ33571698-2E665B56-4B33-471B-AFF3-308ACF880725Q33916899-71046D4C-34CC-42EC-84A9-6AE1E5FFCBF1Q34069150-7729CE3C-54FF-43B2-B08F-A237F66A3392Q34351357-038E3ABA-96DF-4B3E-B5EF-911A04E4D59AQ34657518-91117805-4ACD-4239-B71D-CA329CB39D53Q34691719-BB6016AA-D92A-467B-9C42-CD530324B419Q35375003-D68D4171-8742-493C-988D-5D8B0E1E9996Q35854671-78E88D04-2556-4B9F-9057-8B03007AF8C1Q35900421-18A95458-ABF3-4A2D-9E0E-FBBA2D43C250Q35909002-6398A83D-8208-401A-8C86-C60D5F5BB5BEQ36197118-AF7A9419-900E-4468-98D8-436285E8340EQ36240954-C467B8C6-4E69-4F13-8022-78C852628B38Q36275097-7A5A5BE9-7099-4F85-B659-4C3884C799A5Q36303429-5D579C80-D09B-4873-9D2E-64924B2C0915Q36314787-773B7AC3-17CB-48C8-AEBB-4C1F4E1D92F5Q36361079-6A6CF74E-A4E1-44DF-89A1-07317898C81EQ36397824-3675D1AF-6F6F-4A34-B091-DB879C5109FDQ36567487-C17D6206-1BEA-48DA-A5AF-953AEB3CF754Q36704494-5D287E1B-5ED0-4B93-ABD2-AD8AA254A904Q36789430-B574D42A-2F84-4D02-A064-1D2EBF2BDFA4Q36849670-2CA649C8-B93D-453E-A130-C163EBD7A4E5Q36909418-8362DEC3-B4EB-4B24-8A89-6B699E4D208CQ36963403-6FABC3D7-4809-47A2-9045-2FE9908D8FACQ37011929-C91F1DBA-2D0D-4401-9B35-FC57A978E1F9Q37102122-3A9E9CE0-F715-49C3-BD1C-46BE11E0EFCCQ37117139-E1D3B5C4-0E13-453E-BDC5-72A0259FDB26Q37172220-A5B24CA1-6A1D-41B3-9F81-9964DF46C0F0Q37233065-3748460B-09E7-49DC-A266-6B04283119C2Q37427226-D4F3DDEA-1A68-4AB8-B879-D6A35103C8EEQ37450153-4B235741-3554-42E7-847C-EB68EDBE3C18Q37478694-41FC7D00-57B3-41B3-BAFD-530EDF55FCA2Q37507410-2CD101DF-E913-405C-AE91-4C4977D8F13BQ37549886-0D0679A0-3651-45B6-9982-F629BBC9F36B
P2860
Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Essential elements of genetic ...... Society of Genetic Counselors.
@en
Essential elements of genetic ...... Society of Genetic Counselors.
@nl
type
label
Essential elements of genetic ...... Society of Genetic Counselors.
@en
Essential elements of genetic ...... Society of Genetic Counselors.
@nl
prefLabel
Essential elements of genetic ...... Society of Genetic Counselors.
@en
Essential elements of genetic ...... Society of Genetic Counselors.
@nl
P2093
P1476
Essential elements of genetic ...... Society of Genetic Counselors.
@en
P2093
Angela M Trepanier
Bronson D Riley
Cécile Skrzynia
Faith Callif-Daley
Josephine W Costalas
Julie O Culver
June A Peters
Katherine S Hunt
Leigha A Senter
Nancie M Petrucelli
P304
P356
10.1007/S10897-011-9462-X
P577
2011-12-02T00:00:00Z